Literature DB >> 33074338

Pyoderma Gangrenosum Revealing Myeloid Activation of Fanconi Anaemia: Two Case Reports.

Alexandra Mokrzycki1, Coralie Lheure, Nathalie Franck, Gérard Socié, Clémence Mauppin, Flore Sicre de Fontbrune, Régis Peffault de Latour, Clémence Lepelletier, Adèle de Masson, Maxime Battistella, Guy Leverger, Pierre Sohier, Jean-David Bouaziz, Nicolas Dupin.   

Abstract

Entities:  

Keywords:  Fanconi anemia; neutrophil infiltration; pyoderma gangrenosum

Mesh：

Year:  2020        PMID： 33074338      PMCID： PMC9309707          DOI： 10.2340/00015555-3671

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  16 in total

1.  Sweet syndrome in patients with Fanconi anaemia: association with extracutaneous manifestations and progression of haematological disease.

Authors:  Lisa Giulino; Eva C Guinan; Alfred P Gillio; Richard A Drachtman; Julie Teruya-Feldstein; Farid Boulad
Journal:  Br J Haematol       Date:  2011-04-19       Impact factor: 6.998

2.  Pyoderma gangrenosum: a presenting sign of myelodysplastic syndrome in undiagnosed Fanconi anemia.

Authors:  Prasanthi Kandula; Kishan M Shah; Jay E Wolverton; Cuong Le; Stephen E Wolverton
Journal:  Dermatol Online J       Date:  2019-01-15

3.  Canakinumab in adults with steroid-refractory pyoderma gangrenosum.

Authors:  A G A Kolios; J-T Maul; B Meier; K Kerl; C Traidl-Hoffmann; M Hertl; D Zillikens; M Röcken; J Ring; A Facchiano; C Mondino; N Yawalkar; E Contassot; A A Navarini; L E French
Journal:  Br J Dermatol       Date:  2015-10-16       Impact factor: 9.302

4.  Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet's Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils.

Authors:  Marie Passet; Clémence Lepelletier; Marie-Dominique Vignon-Pennamen; François Chasset; Pierre Hirsch; Maxime Battistella; Paul Duriez; Flore Sicre de Fontbrune; Nicolas Boissel; Ollivier Legrand; Emmanuel Raffoux; Martine Bagot; Lionel Adès; Emmanuelle Clappier; Jean-David Bouaziz
Journal:  J Invest Dermatol       Date:  2020-02-17       Impact factor: 8.551

5.  Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.

Authors:  T Ljung; M Staun; O Grove; O Fausa; M H Vatn; P M Hellström
Journal:  Scand J Gastroenterol       Date:  2002-09       Impact factor: 2.423

Review 6.  Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment.

Authors:  Afsaneh Alavi; Lars E French; Mark D Davis; Alain Brassard; Robert S Kirsner
Journal:  Am J Clin Dermatol       Date:  2017-06       Impact factor: 7.403

7.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

Review 8.  Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

Authors:  Khalaf Kridin; Arnon D Cohen; Kyle T Amber
Journal:  Am J Clin Dermatol       Date:  2018-08       Impact factor: 7.403

Review 9.  Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives.

Authors:  Pellegrino Musto
Journal:  Leuk Res       Date:  2004-04       Impact factor: 3.156

10.  Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Authors:  Anthony D Ormerod; Kim S Thomas; Fiona E Craig; Eleanor Mitchell; Nicola Greenlaw; John Norrie; James M Mason; Shernaz Walton; Graham A Johnston; Hywel C Williams
Journal:  BMJ       Date:  2015-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.